Global Information
회사소개 | 문의 | 비교리스트

세계의 인공 혈관 시장

Vascular Grafts

리서치사 Global Industry Analysts, Inc.
발행일 2022년 01월 상품 코드 939529
페이지 정보 영문 377 Pages
가격
US $ 5,450 ₩ 6,564,000 PDF (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 16,350 ₩ 19,693,000 PDF (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 인공 혈관 시장 Vascular Grafts
발행일 : 2022년 01월 페이지 정보 : 영문 377 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

COVID-19의 위기와 다가오는 경제 불황 가운데, 세계의 인공 혈관 시장은 예측기간 중 6.1%의 CAGR로 성장할 전망입니다. 혈관내 동맥류 수복(EVAR) 부문은 6.8% 이상의 성장이 전망되며, 예측기간 말까지 19억 달러에 달할 것으로 예측됩니다. 새로운 시나리오에서는 미국의 CAGR이 4.9%로 수정되고 있습니다. 독일은 향후 7-8년간 4,630만 달러 이상의 시장 규모 확대가 예측됩니다. 일본의 혈관내 동맥류 수복(EVAR) 부문은 예측기간 말까지 8,100만 달러에 달할 전망입니다.

조사 대상 기업 사례

  • Maquet Holding B.V. & Co. KG; Medtronic PLC; Terumo Cardiovascular Group; B. Braun Melsungen AG; BARD, A Becton, Dickinson Company; Cardinal Health, Inc.; Cook Medical LLC; Endologix, Inc.; Gore Medical; LeMaitre Vascular, Inc.

세계의 인공 혈관(Vascular Grafts) 시장에 대해 조사했으며, 시장 개요, COVID-19가 미치는 영향, 지역·국가별 분석과 예측 및 주요 기업 개요 등 체계적인 정보를 제공합니다.

제1부 서론, 조사 방법, 조사 범위

제2부 주요 요약

제1장 시장 개요

  • 세계 경쟁사의 시장 점유율
  • 경쟁사의 시장 점유율 시나리오
  • Covid-19의 영향과 다가오는 세계의 경기후퇴

제2장 주요 기업

제3장 시장 동향과 성장 촉진요인

제4장 세계 시장 전망

제3부 시장 분석

  • 지역별 시장 분석
  • 미국
    • 시장 데이터
    • 미국 시장 점유율 : 기업별
    • 시장 분석
  • 캐나다
  • 일본
  • 중국
  • 유럽
    • 시장 데이터
    • 경쟁사의 시장 점유율 시나리오
    • 시장 분석
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • UAE
  • 기타 중동
  • 아프리카

제4부 경쟁

  • 기업 개요
KSM 20.06.19

Abstract:

Global Vascular Grafts Market to Reach US$4.4 Billion by the Year 2026

Vascular grafts are implants that are used during surgical procedures that involve peripheral vessel bypass or aortic repair. They are synthetic tubes that are surgically implanted in the arteries and veins to repair diseased or injured areas in the arteries. Vascular grafts are also used to patch up whole segments of the aorta and other larger arteries. By harnessing the vascular grafts, damaged or diseased blood vessels are replaced or patched up to redirect the blood flow. Vascular grafts come in an array of materials, such as biosynthetic, polyester, polyurethane, and polytetrafluoroethylene (ePTFE). While vascular grafts are largely used in the heart during a coronary artery bypass, they are also deployed to treat renal failure, vascular occlusion, vascular disease, and aneurysm. The increasing prevalence of diabetes, hypertension, vascular occlusions, end-stage renal disease, and peripheral artery diseases has been a growth driver for the vascular graft treatment market. There is greater public awareness of coronary diseases brought about by sedentary lifestyles, unhealthy eating habits, and smoking. Vascular grafts are also deployed for kidney transplants for repairing renal vessels.

Amid the COVID-19 crisis, the global market for Vascular Grafts estimated at US$3.1 Billion in the year 2020, is projected to reach a revised size of US$4.4 Billion by 2026, growing at a CAGR of 6.4% over the analysis period. Endovascular Aneurysm Repair (EVAR), one of the segments analyzed in the report, is projected to grow at a 6.2% CAGR to reach US$2.1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Peripheral Vascular Repair segment is readjusted to a revised 8% CAGR for the next 7-year period. This segment currently accounts for a 32.7% share of the global Vascular Grafts market. The endovascular grafts dominated market share, fueled by the surging demand for sophisticated endovascular grafts. Anaconda AAA Stent Graft System of Terumo and Endurant II AAA Stent Graft System of Medtronic are the main products in the market. Increasing R&D and new product introductions are expected to foster market growth.

The U.S. Market is Estimated at $1.3 Billion in 2021, While China is Forecast to Reach $486.7 Million by 2026

The Vascular Grafts market in the U.S. is estimated at US$1.3 Billion in the year 2021. The country currently accounts for a 40.2% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$486.7 Million in the year 2026 trailing a CAGR of 8.4% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR while Rest of European market (as defined in the study) will reach US$213.4 Million by the end of the analysis period.

Hemodialysis Access Segment to Reach $876 Million by 2026

The hemodialysis vascular graft market has been registering healthy demand, attributed to the growing prevalence of kidney diseases worldwide. Further, the rising use of biological access products on account of technological developments is also driving market growth. Rising number of patients with renal impairment and low availability of kidney donors are encouraging hemodialysis procedures in such patients, which is boosting market prospects. In the global Hemodialysis Access segment, USA, Canada, Japan, China and Europe will drive the 4.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$590.8 Million in the year 2020 will reach a projected size of US$793.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$68.9 Million by the year 2026, while Latin America will expand at a 4.9% CAGR through the analysis period.

Select Competitors (Total 44 Featured) -

  • Maquet Holding B.V. & Co. KG
  • Medtronic PLC
  • Terumo Cardiovascular Group
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Endologix, Inc.
  • Gore Medical
  • LeMaitre Vascular, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • A Prelude to Vascular Grafting
    • Impact of Covid-19 and a Looming Global Recession
    • 2020 Marked as a Year of Disruption & Transformation
    • COVID-19 and Vascular Grafts Market
    • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
    • EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
    • Impact of COVID-19 Outbreak on Elective Surgeries
    • Global Market Prospects and Overview
    • Vascular Grafts Market Set for a Rapid Growth
    • Endovascular Stent-Grafts Account for Larger Share
    • Competition
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Cardio Vascular Disease Bodes Well for the Global Vascular Graft Market
    • EXHIBIT 2: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • EXHIBIT 3: Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
    • Rising Preference for Minimally Invasive Procedures Boosts Market Prospects
    • Rising Prevalence of Kidney Diseases Drives the Global Hemodialysis Vascular Graft Market
    • Hemodialysis Remains the Major Modality for Dialysis Treatment - A Key Opportunity
    • EXHIBIT 4: Global Dialysis Patient Population Distribution by Modality for Select Countries (2020): Percentage Breakdown of Hemodialysis (HD) and Peritoneal Dialysis (PD) Patients
    • EXHIBIT 5: Global Population of ESRD Patients Undergoing Therapy by Type of Treatment (2020): Percentage Breakdown of Patients Receiving Hemodialysis, Kidney Transplants, and Peritoneal Dialysis
    • Home Hemodialysis: A Niche Albeit High Potential Market
    • EXHIBIT 6: World Dialysis Clinics Market by Region (2019): Percentage Breakdown of Patients Treated by Type of Operator
    • EXHIBIT 7: Global Dialysis Market by Region: Percentage Breakdown of Patients Receiving Dialysis Treatment in In-Centre and Home Settings for 2019
    • Aging Population Drives Demand for Vascular Grafts
    • Increasing Healthcare Expenditure to Foster Growth
    • EXHIBIT 8: World Healthcare Expenditure (In US$ Trillion) for the Years 2016 & 2018
    • Rising Middle Class Population Aids Growth
    • EXHIBIT 9: Global Middle Class Population (in Millions) and as a Percentage of Total Population: 2005, 2015, 2025 & 2035
    • EXHIBIT 10: Global Middle Class Spending (in US$ Trillion) by Geographic Region
    • Risk of CAD in Obesity Offers Prospects for Coronary Stenting
    • EXHIBIT 11: Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
    • Cell-Free Tissue Engineered Vascular Grafts Aid in Vascular Remodelling
    • Cells for Cells Develops VEINTIS™
    • New Approach for Optimizing TEVGs
    • 3D Printed Vascular Scaffolds Hold Potential to be the New-Age TEVGs
    • A Review of Select Vascular Developments
    • Some of the important vascular innovations expected in the near-term include:
    • Offerings of Moving Analytics and Vasctrac
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Vascular Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Vascular Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
    • TABLE 4: World Current & Future Analysis for Endovascular Aneurysm Repair (EVAR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Endovascular Aneurysm Repair (EVAR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Endovascular Aneurysm Repair (EVAR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 7: World Current & Future Analysis for Peripheral Vascular Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Peripheral Vascular Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Peripheral Vascular Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 10: World Current & Future Analysis for Hemodialysis Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Hemodialysis Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Hemodialysis Access by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 13: World Current & Future Analysis for Polyester by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Polyester by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Polyester by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 16: World Current & Future Analysis for ePTFE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for ePTFE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for ePTFE by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 19: World Current & Future Analysis for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Polyurethane by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Polyurethane by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 22: World Current & Future Analysis for Biosynthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Biosynthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Biosynthetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 25: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
    • TABLE 28: World Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 31: USA Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 34: USA Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: USA Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: USA 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 37: USA Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: USA Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: USA 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • CANADA
    • TABLE 40: Canada Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Canada Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Canada 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 43: Canada Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Canada Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Canada 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 46: Canada Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Canada Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Canada 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • JAPAN
    • TABLE 49: Japan Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Japan Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Japan 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 52: Japan Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Japan Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Japan 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 55: Japan Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Japan Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Japan 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • CHINA
    • TABLE 58: China Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: China Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: China 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 61: China Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: China Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: China 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 64: China Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: China Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: China 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • EUROPE
    • TABLE 67: Europe Current & Future Analysis for Vascular Grafts by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 68: Europe Historic Review for Vascular Grafts by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Europe 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
    • TABLE 70: Europe Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Europe Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Europe 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 73: Europe Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Europe Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Europe 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 76: Europe Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Europe Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: Europe 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • FRANCE
    • TABLE 79: France Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: France Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: France 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 82: France Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: France Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: France 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 85: France Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: France Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: France 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • GERMANY
    • TABLE 88: Germany Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Germany Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Germany 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 91: Germany Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Germany Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Germany 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 94: Germany Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Germany Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Germany 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • ITALY
    • TABLE 97: Italy Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Italy Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Italy 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 100: Italy Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Italy Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Italy 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 103: Italy Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Italy Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Italy 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • UNITED KINGDOM
    • TABLE 106: UK Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 107: UK Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: UK 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 109: UK Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: UK Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: UK 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 112: UK Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: UK Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: UK 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • SPAIN
    • TABLE 115: Spain Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Spain Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: Spain 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 118: Spain Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Spain Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: Spain 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 121: Spain Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: Spain Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: Spain 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • RUSSIA
    • TABLE 124: Russia Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: Russia Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: Russia 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 127: Russia Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: Russia Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: Russia 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 130: Russia Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: Russia Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: Russia 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • REST OF EUROPE
    • TABLE 133: Rest of Europe Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Rest of Europe Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Rest of Europe 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 136: Rest of Europe Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Rest of Europe Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Rest of Europe 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 139: Rest of Europe Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 140: Rest of Europe Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Rest of Europe 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • ASIA-PACIFIC
    • TABLE 142: Asia-Pacific Current & Future Analysis for Vascular Grafts by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 143: Asia-Pacific Historic Review for Vascular Grafts by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Asia-Pacific 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
    • TABLE 145: Asia-Pacific Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Asia-Pacific Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Asia-Pacific 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 148: Asia-Pacific Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Asia-Pacific Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Asia-Pacific 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 151: Asia-Pacific Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Asia-Pacific Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Asia-Pacific 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • AUSTRALIA
    • TABLE 154: Australia Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Australia Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Australia 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 157: Australia Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Australia Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: Australia 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 160: Australia Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Australia Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 162: Australia 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • INDIA
    • TABLE 163: India Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: India Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 165: India 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 166: India Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 167: India Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 168: India 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 169: India Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: India Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 171: India 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • SOUTH KOREA
    • TABLE 172: South Korea Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 173: South Korea Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 174: South Korea 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 175: South Korea Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: South Korea Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 177: South Korea 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 178: South Korea Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: South Korea Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 180: South Korea 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 181: Rest of Asia-Pacific Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Rest of Asia-Pacific Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 183: Rest of Asia-Pacific 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 184: Rest of Asia-Pacific Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Rest of Asia-Pacific Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 186: Rest of Asia-Pacific 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 187: Rest of Asia-Pacific Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Rest of Asia-Pacific Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 189: Rest of Asia-Pacific 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • LATIN AMERICA
    • TABLE 190: Latin America Current & Future Analysis for Vascular Grafts by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 191: Latin America Historic Review for Vascular Grafts by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 192: Latin America 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
    • TABLE 193: Latin America Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 194: Latin America Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 195: Latin America 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 196: Latin America Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 197: Latin America Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 198: Latin America 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 199: Latin America Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: Latin America Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 201: Latin America 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • ARGENTINA
    • TABLE 202: Argentina Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 203: Argentina Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 204: Argentina 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 205: Argentina Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Argentina Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 207: Argentina 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 208: Argentina Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Argentina Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 210: Argentina 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • BRAZIL
    • TABLE 211: Brazil Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 212: Brazil Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 213: Brazil 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 214: Brazil Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 215: Brazil Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 216: Brazil 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 217: Brazil Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 218: Brazil Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 219: Brazil 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • MEXICO
    • TABLE 220: Mexico Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 221: Mexico Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 222: Mexico 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 223: Mexico Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 224: Mexico Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 225: Mexico 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 226: Mexico Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 227: Mexico Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 228: Mexico 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • REST OF LATIN AMERICA
    • TABLE 229: Rest of Latin America Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 230: Rest of Latin America Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 231: Rest of Latin America 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 232: Rest of Latin America Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 233: Rest of Latin America Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 234: Rest of Latin America 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 235: Rest of Latin America Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 236: Rest of Latin America Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 237: Rest of Latin America 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • MIDDLE EAST
    • TABLE 238: Middle East Current & Future Analysis for Vascular Grafts by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 239: Middle East Historic Review for Vascular Grafts by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 240: Middle East 15-Year Perspective for Vascular Grafts by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
    • TABLE 241: Middle East Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 242: Middle East Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 243: Middle East 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 244: Middle East Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 245: Middle East Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 246: Middle East 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 247: Middle East Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 248: Middle East Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 249: Middle East 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • IRAN
    • TABLE 250: Iran Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 251: Iran Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 252: Iran 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 253: Iran Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 254: Iran Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 255: Iran 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 256: Iran Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 257: Iran Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 258: Iran 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • ISRAEL
    • TABLE 259: Israel Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 260: Israel Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 261: Israel 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 262: Israel Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 263: Israel Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 264: Israel 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 265: Israel Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 266: Israel Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 267: Israel 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • SAUDI ARABIA
    • TABLE 268: Saudi Arabia Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 269: Saudi Arabia Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 270: Saudi Arabia 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 271: Saudi Arabia Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 272: Saudi Arabia Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 273: Saudi Arabia 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 274: Saudi Arabia Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 275: Saudi Arabia Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 276: Saudi Arabia 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 277: UAE Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 278: UAE Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 279: UAE 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 280: UAE Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 281: UAE Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 282: UAE 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 283: UAE Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 284: UAE Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 285: UAE 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • REST OF MIDDLE EAST
    • TABLE 286: Rest of Middle East Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 287: Rest of Middle East Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 288: Rest of Middle East 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 289: Rest of Middle East Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 290: Rest of Middle East Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 291: Rest of Middle East 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 292: Rest of Middle East Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 293: Rest of Middle East Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 294: Rest of Middle East 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027
  • AFRICA
    • TABLE 295: Africa Current & Future Analysis for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 296: Africa Historic Review for Vascular Grafts by Indication - Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 297: Africa 15-Year Perspective for Vascular Grafts by Indication - Percentage Breakdown of Value Sales for Endovascular Aneurysm Repair (EVAR), Peripheral Vascular Repair and Hemodialysis Access for the Years 2012, 2021 & 2027
    • TABLE 298: Africa Current & Future Analysis for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 299: Africa Historic Review for Vascular Grafts by Raw Material - Polyester, ePTFE, Polyurethane and Biosynthetic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 300: Africa 15-Year Perspective for Vascular Grafts by Raw Material - Percentage Breakdown of Value Sales for Polyester, ePTFE, Polyurethane and Biosynthetic for the Years 2012, 2021 & 2027
    • TABLE 301: Africa Current & Future Analysis for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 302: Africa Historic Review for Vascular Grafts by End-Use - Hospitals and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 303: Africa 15-Year Perspective for Vascular Grafts by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgical Centers for the Years 2012, 2021 & 2027

IV. COMPETITION

  • Total Companies Profiled: 44
Back to Top
전화 문의
F A Q